chr5-78162865-A-C

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_003664.5(AP3B1):​c.1317T>G​(p.Thr439Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00549 in 1,614,064 control chromosomes in the GnomAD database, including 32 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0052 ( 0 hom., cov: 32)
Exomes š‘“: 0.0055 ( 32 hom. )

Consequence

AP3B1
NM_003664.5 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: -0.928
Variant links:
Genes affected
AP3B1 (HGNC:566): (adaptor related protein complex 3 subunit beta 1) This gene encodes a protein that may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. The encoded protein is part of the heterotetrameric AP-3 protein complex which interacts with the scaffolding protein clathrin. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 2. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 5-78162865-A-C is Benign according to our data. Variant chr5-78162865-A-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 178704.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Benign=2, Uncertain_significance=1}. Variant chr5-78162865-A-C is described in Lovd as [Benign]. Variant chr5-78162865-A-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-0.928 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.00516 (786/152342) while in subpopulation AMR AF= 0.0123 (189/15310). AF 95% confidence interval is 0.0109. There are 0 homozygotes in gnomad4. There are 379 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 32 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP3B1NM_003664.5 linkc.1317T>G p.Thr439Thr synonymous_variant Exon 13 of 27 ENST00000255194.11 NP_003655.3 O00203-1A0A0S2Z5J4
AP3B1NM_001271769.2 linkc.1170T>G p.Thr390Thr synonymous_variant Exon 13 of 27 NP_001258698.1 O00203-3A0A0S2Z5J4
AP3B1NM_001410752.1 linkc.1317T>G p.Thr439Thr synonymous_variant Exon 13 of 23 NP_001397681.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP3B1ENST00000255194.11 linkc.1317T>G p.Thr439Thr synonymous_variant Exon 13 of 27 1 NM_003664.5 ENSP00000255194.7 O00203-1

Frequencies

GnomAD3 genomes
AF:
0.00517
AC:
787
AN:
152224
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00128
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0124
Gnomad ASJ
AF:
0.0150
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00574
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00610
Gnomad OTH
AF:
0.00526
GnomAD3 exomes
AF:
0.00460
AC:
1156
AN:
251326
Hom.:
3
AF XY:
0.00451
AC XY:
612
AN XY:
135824
show subpopulations
Gnomad AFR exome
AF:
0.000861
Gnomad AMR exome
AF:
0.00477
Gnomad ASJ exome
AF:
0.0116
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00173
Gnomad FIN exome
AF:
0.00592
Gnomad NFE exome
AF:
0.00568
Gnomad OTH exome
AF:
0.00538
GnomAD4 exome
AF:
0.00553
AC:
8082
AN:
1461722
Hom.:
32
Cov.:
31
AF XY:
0.00538
AC XY:
3911
AN XY:
727166
show subpopulations
Gnomad4 AFR exome
AF:
0.000627
Gnomad4 AMR exome
AF:
0.00521
Gnomad4 ASJ exome
AF:
0.0119
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00181
Gnomad4 FIN exome
AF:
0.00579
Gnomad4 NFE exome
AF:
0.00603
Gnomad4 OTH exome
AF:
0.00563
GnomAD4 genome
AF:
0.00516
AC:
786
AN:
152342
Hom.:
0
Cov.:
32
AF XY:
0.00509
AC XY:
379
AN XY:
74496
show subpopulations
Gnomad4 AFR
AF:
0.00127
Gnomad4 AMR
AF:
0.0123
Gnomad4 ASJ
AF:
0.0150
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00124
Gnomad4 FIN
AF:
0.00574
Gnomad4 NFE
AF:
0.00609
Gnomad4 OTH
AF:
0.00521
Alfa
AF:
0.00561
Hom.:
1
Bravo
AF:
0.00514
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
Feb 21, 2013
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Thr439Thr in exon 13 of AP3B1: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 0.5% (47/8600) of E uropean American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs75248449). -

Jun 05, 2018
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not provided Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Nov 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

AP3B1: BP4, BP7, BS2 -

Hermansky-Pudlak syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hermansky-Pudlak syndrome 2 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autoinflammatory syndrome Benign:1
Jan 19, 2017
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.28
DANN
Benign
0.37

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs75248449; hg19: chr5-77458689; API